AXSM
Axsome Therapeutics Inc
Halal Rating :
Last Price
$91.87
Last updated:
Market Cap
-
7D Change
2.91%
1 Year Change
1.04%
Company Overview
Industries
Exchange
Next Earnings Date
Axsome Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes novel therapies for central nervous system (CNS) disorders. The company's key products include Auvelity® for major depressive disorder and Sunosi® for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
The company focuses on developing innovative treatments for conditions with limited treatment options, leveraging its proprietary drug development platform to create differentiated therapeutic solutions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $104.76m | $167.39m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $87.17m | $165.21m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $75.0m | $142.27m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Axsome Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.